Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori
Clinical trial NCT05577468 · COMPLETED
Trial details
- NCT number
- NCT05577468
- Sponsor
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-30
- Primary completion
- 2023-09-30
- Enrollment
- 561
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.